Overview
DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Tech Stack
Funding History
Post Ipo Equity
$10.3M
Sep 2018
Post Ipo Equity
$21.3M
Oct 2019
Post Ipo Equity
$28.6M
Jul 2020
Post Ipo Equity
$70.0M
Jan 2021
Farallon Capital Management, Driehaus Capital Management, Nantahala Capital Management +3
Post Ipo Debt
$50.0M
Jun 2022
OrbiMed
Post Ipo Equity
$14.3M
May 2023
Post Ipo Equity
$22.4M
Dec 2023
SternAegis
Post Ipo Equity
$25.6M
Jan 2025
Post Ipo Debt
$32.5M
May 2025
Rand Capital, Callodine Group
Post Ipo Equity
$17.5M
Sep 2025